Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00477113 · ClinicalTrials.gov registry record
TYSABRI Global Observational Program in Safety
A clinical trial, sponsored by Biogen.
- Completed
- Registry status
- 2,207
- Enrollment target
NCT00477113 is a clinical trial that has completed, run by Biogen. The registered enrollment target is 2,207 participants.
The verdict
NCT00477113 has completed, sponsored by Biogen.
- COMPLETED
- Registry status
- 2,207 participants
- Enrollment target
Study Summary
The Primary objective of this study is to determine the incidence and pattern of serious infections, malignancies, and other serious adverse events (SAE) in participants with multiple sclerosis (MS) treated with Tysabri (natalizumab).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,207 participants |
| Start Date | 2007-01 |
| Est. Completion | 2015-05 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00477113
The ClinicalTrials.gov registry entry for NCT00477113 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,207 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Biogen, which has 334 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT00477113 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00477113 about?
NCT00477113 is a clinical study titled "TYSABRI Global Observational Program in Safety". The Primary objective of this study is to determine the incidence and pattern of serious infections, malignancies, and other serious adverse events (SAE) in participants with multiple sclerosis (MS) treated with Tysabri (natalizumab).
What is the current status of trial NCT00477113?
This trial is currently completed. The enrollment target is 2,207 participants. The study started on 2007-01. Estimated completion is 2015-05.
Who is sponsoring clinical trial NCT00477113?
This trial is sponsored by Biogen, which has 334 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.